What is the recommended dosing regimen for ketorolac (Toradol) in pediatric patients, including dose per kilogram, maximum dose, dosing interval, duration of therapy, and contraindications?

Pediatric Ketorolac (Toradol) Dosing

Ketorolac is NOT FDA-approved for pediatric use, and the FDA drug label explicitly states "Ketorolac tromethamine is not indicated for use in pediatric patients." 1 Despite this, ketorolac is widely used off-label in pediatric practice, particularly for postoperative pain management.

Recommended Dosing Regimen

Standard Dose

The most commonly supported pediatric dose is 0.5 mg/kg IV/IM every 6 hours, with a maximum single dose of 15-30 mg. 2, 3, 4

• Initial/Loading dose: 0.5 mg/kg IV (some sources support up to 1 mg/kg as a single loading dose) 5, 3
• Maintenance dose: 0.5 mg/kg every 6 hours 2, 4
• Alternative maintenance: 0.15-0.2 mg/kg every 6 hours (maximum 10 mg per dose) for short-term therapy 2
• Continuous infusion: 0.17 mg/kg/hour (if bolus dosing is used initially) 3

Maximum Doses

• Single dose maximum: 30 mg (though recent evidence suggests 15 mg may be equally effective in patients ≥60 kg) 6
• Daily maximum: 90 mg 3
• Maximum duration: 48 hours is recommended for safety, though FDA labeling for adults allows up to 5 days 1, 3, 4

Age-Specific Considerations

• NOT recommended for infants <6 months due to increased risk of acute kidney injury 7
• Infants 6-12 months: Use with extreme caution; limited safety data 3
• Children ≥1 year: Standard dosing applies 3

Route of Administration

• IV preferred during immediate postoperative period 3
• IM acceptable if IV access unavailable, though not preferred in children due to injection pain 3
• Oral: 0.25 mg/kg up to maximum 1 mg/kg/day for up to 7 days (when transitioning from parenteral) 3

Duration of Therapy

Maximum 48 hours for IV/IM use in pediatric patients to minimize renal and bleeding risks 2, 3, 4. The adult FDA limit of 5 days should not be extrapolated to children without careful monitoring.

Contraindications (Pediatric-Specific)

Absolute Contraindications

• Age <6 months (particularly in cardiac surgery patients) 7
• Pre-existing renal dysfunction 7
• Active bleeding or coagulation disorders 1
• History of peptic ulcer disease or GI bleeding 1
• Single-ventricle palliation (congenital heart disease) 7
• Concomitant aspirin use 7

Relative Contraindications/Use With Caution

• Infants 6-12 months: Very limited safety data 3
• Hypovolemia or dehydration: Increased renal toxicity risk 1
• Concurrent nephrotoxic medications 7
• Tonsillectomy: Dose-dependent bleeding risk (see below) 8

Safety Considerations

Bleeding Risk

High-dose ketorolac (0.9-1.0 mg/kg) significantly increases primary operative bleeding control (OR 4.07) and significant bleeding (OR 2.32) in tonsillectomy patients, while 0.5 mg/kg does NOT increase these risks. 8 This provides strong evidence for using the lower 0.5 mg/kg dose, particularly in surgeries with high bleeding risk.

Renal Effects

• Infants <6 months: Ketorolac causes significant creatinine elevation when used for 48 hours, though values may remain within normal limits 7
• Monitor creatinine in all patients, especially those with risk factors 7
• Ensure adequate hydration before and during therapy 1

Cardiac Surgery Considerations

Recent data in neonates post-cardiac surgery using 0.5 mg/kg every 6 hours showed no clinically significant renal dysfunction or bleeding events 4, suggesting this dose may be safe in carefully selected cardiac patients, though infants <6 months with single-ventricle physiology remain high-risk 7.

Clinical Pearls

Opioid-Sparing Effects

Ketorolac demonstrates significant opioid-sparing capacity, reducing morphine consumption by approximately 1.58 mg IV morphine equivalents in the first 4 hours post-surgery 9. When combined with acetaminophen, it provides excellent multimodal analgesia 7.

Dose Ceiling Effect

Recent evidence suggests a ceiling effect at 15 mg in adolescents ≥60 kg, with no additional benefit from 30 mg doses 6. Similarly, adult data support ceiling effects at lower doses 10, suggesting that higher per-kilogram doses may not provide additional analgesia while increasing toxicity risk.

Practical Dosing Algorithm

1. Verify age ≥6 months and weight
2. Check for contraindications (renal dysfunction, bleeding risk, single-ventricle physiology, aspirin use)
3. Calculate dose: 0.5 mg/kg IV
4. Apply maximum: 15 mg for patients ≥60 kg; 30 mg for exceptional cases with careful monitoring
5. Administer every 6 hours as needed
6. Limit duration to 48 hours
7. Monitor: Pain scores, urine output, bleeding, creatinine (if risk factors present)

Common Pitfalls to Avoid

• Do not use in infants <6 months, especially post-cardiac surgery with risk factors 7
• Do not exceed 48 hours of therapy without compelling justification 3, 4
• Do not use 0.9-1.0 mg/kg doses in tonsillectomy due to bleeding risk 8
• Do not assume adult dosing applies: Pediatric pharmacokinetics differ significantly 1, 3